Join
Live feed
·
INSIDERFilingvia Quantisnow
Chinook Therapeutics Inc. logo

SEC Form 4: Jerel Davis acquired 28,388 shares as part of a pre-agreed trading plan and disposed of 735,873 shares as part of a pre-agreed trading plan, increasing direct ownership by 0.34% to 732,938 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KDNY (Chinook Therapeutics Inc.) and more on Quantisnow.